Guest Column | July 28, 2026

4 Hidden Gaps In Clinical Trial Preparation For Small Biotechs

By Jessica Cordes, senior consultant, Clinical Excellence GmbH

For many small biotechs, the transition into clinical development represents years of scientific work, significant investment, and high expectations. Yet despite strong science and promising early data, some clinical trials fail to meet timelines, struggle with enrollment, or face costly operational disruptions.

The reason is rarely a lack of scientific innovation. More often, failure is embedded in the way the clinical trial was prepared.

Please read the full Clinical Leader Article.